ANF vs BBWI

ANF has a stable Piotroski F-Score of 6/9, indicating moderate financial health, but lacks an Altman Z-Score, limiting definitive conclusions on bankruptcy risk. The stock trades above both the Graham Number ($81.46) and intrinsic value estimate ($71.89), suggesting overvaluation, despite strong profitability metrics like 40.89% ROE and 12.77% ROA. While revenue growth is positive at 6.80%, earnings are contracting YoY (-5.6%) and QoQ (-14.4%), and insider selling signals caution. Analysts recommend a 'buy' with a high target price of $127.56, but recent price performance shows significant short-term weakness (-24% in 1M).

BBWI's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. The stock appears undervalued based on a low P/E of 6.87 and an intrinsic value estimate of $22.61, close to the current price of $22.20. However, declining revenue and earnings growth, along with negative Price/Book, raise sustainability concerns. While profitability margins and ROA are strong relative to peers, weak recent earnings surprises and bearish technical trends cap upside potential.